These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7645203)

  • 1. Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice.
    McMinn PC; Lee E; Hartley S; Roehrig JT; Dalgarno L; Weir RC
    Virology; 1995 Aug; 211(1):10-20. PubMed ID: 7645203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the spread of Murray Valley encephalitis viruses of high or low neuroinvasiveness in the tissues of Swiss mice after peripheral inoculation.
    McMinn PC; Dalgarno L; Weir RC
    Virology; 1996 Jun; 220(2):414-23. PubMed ID: 8661392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovirulence and neuroinvasiveness of Murray Valley encephalitis virus mutants selected by passage in a monkey kidney cell line.
    McMinn PC; Marshall ID; Dalgarno L
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():865-72. PubMed ID: 9049332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse-attenuated envelope protein variant of Murray Valley encephalitis virus with altered fusion activity.
    McMinn PC; Weir RC; Dalgarno L
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2085-8. PubMed ID: 8811007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
    Lee E; Lobigs M
    J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA.
    Hurrelbrink RJ; Nestorowicz A; McMinn PC
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3115-3125. PubMed ID: 10567642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein.
    Clark DC; Lobigs M; Lee E; Howard MJ; Clark K; Blitvich BJ; Hall RA
    J Gen Virol; 2007 Apr; 88(Pt 4):1175-1183. PubMed ID: 17374761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.
    Hurrelbrink RJ; McMinn PC
    J Virol; 2001 Aug; 75(16):7692-702. PubMed ID: 11462041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Flavivirus Attenuation Markers Identified in the Envelope Protein of Alfuy Virus.
    Westlake D; Bielefeldt-Ohmann H; Prow NAA; Hall RAA
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice.
    Holzmann H; Stiasny K; Ecker M; Kunz C; Heinz FX
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():31-7. PubMed ID: 9010282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants.
    Cecilia D; Gould EA
    Virology; 1991 Mar; 181(1):70-7. PubMed ID: 1704661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus.
    Kroeger MA; McMinn PC
    Arch Virol; 2002 Jun; 147(6):1155-72. PubMed ID: 12111426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence.
    Lobigs M; Usha R; Nestorowicz A; Marshall ID; Weir RC; Dalgarno L
    Virology; 1990 Jun; 176(2):587-95. PubMed ID: 2161151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virus.
    Lancaster MU; Hodgetts SI; Mackenzie JS; Urosevic N
    J Virol; 1998 Mar; 72(3):2474-82. PubMed ID: 9499109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice.
    Hasegawa H; Yoshida M; Shiosaka T; Fujita S; Kobayashi Y
    Virology; 1992 Nov; 191(1):158-65. PubMed ID: 1329314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry.
    Lee E; Lobigs M
    J Virol; 2000 Oct; 74(19):8867-75. PubMed ID: 10982329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H; Barrett AD
    Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.
    Nickells M; Chambers TJ
    J Virol; 2003 Nov; 77(22):12232-42. PubMed ID: 14581560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence.
    Wu SC; Lian WC; Hsu LC; Liau MY
    Virus Res; 1997 Oct; 51(2):173-81. PubMed ID: 9498615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.